Contribution of BCR-ABL Kinase Domain Mutations to Imatinib Mesylate Resistance in Philadelphia Chromosome Positive Malaysian Chronic Myeloid Leukemia Patients

Hematology Reports - Italy
doi 10.4081/hr.2012.e23
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

PAGEPress Publications

Related search

Imatinib Mesylate Resistance Through BCR-ABL Independence in Chronic Myelogenous Leukemia

Cancer Research
Cancer ResearchOncology
2004English

Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Expressing P190BCR-Abl.

Internal Medicine
Internal MedicineMedicine
2002English

Result of High-Dose Imatinib Mesylate in Patients With Philadelphia Chromosome--Positive Chronic Myeloid Leukemia After Failure of Interferon-

Blood
BiochemistryImmunologyCell BiologyHematology
2003English

Prognostic Significance of Micro RNA 150 Marker in BCR-ABL Positive Chronic Myeloid Leukaemia Patients on Imatinib Mesylate

International Journal of Contemporary Pediatrics
2017English

P210 and P190 BCR-ABL Fusion Transcripts Variants Frequencies Among Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Sudan

International Journal of Biomedical Research
2018English

The Use of Imatinib Resistance Mutation Analysis to Direct Therapy in Philadelphia Chromosome/BCR-Abl1 Positive Chronic Myeloid Leukaemia Patients Failing Imatinib Treatment, in Patan Hospital, Nepal

British Journal of Haematology
Hematology
2017English

BCR-ABL1 Mutations in Patients With Imatinib-Resistant Philadelphia Chromosome-Positive Leukemia by Use of the PCR-Invader Assay

Leukemia Research
Cancer ResearchOncologyHematology
2011English

An Amino-Acid Switch in the BCR-ABL Kinase Domain Modifies Sensitivity to Imatinib Mesylate

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2005English

PECAM-1 Is Involved in BCR/ABL Signaling and May Downregulate Imatinib-Induced Apoptosis of Philadelphia Chromosome-Positive Leukemia Cells

International Journal of Oncology
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy